72,900 Shares in The Cooper Companies, Inc. $COO Acquired by Western Standard LLC

Western Standard LLC purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 72,900 shares of the medical device company’s stock, valued at approximately $5,228,000. Cooper Companies comprises about 1.8% of Western Standard LLC’s holdings, making the stock its 16th biggest holding.

Several other institutional investors and hedge funds have also bought and sold shares of COO. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. Avalon Trust Co purchased a new position in shares of Cooper Companies during the second quarter worth $25,000. SJS Investment Consulting Inc. lifted its position in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the period. Elevation Wealth Partners LLC lifted its position in Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares during the period. Finally, J.Safra Asset Management Corp purchased a new stake in Cooper Companies in the second quarter valued at $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on COO. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Citigroup restated a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $76.73 on Thursday. The company has a market capitalization of $14.96 billion, a PE ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company’s fifty day moving average price is $71.59 and its 200 day moving average price is $71.16. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.